Compare Herbalife Nutrition Ltd (HLF) vs Nu Holdings Ltd (NU) Price & Performance

HLF trades at $11.52, down 6.72% in the past 24 hours, with a bearish technical signal and mixed earnings history. The company reported Q2 2026 net sales of $1.3 billion, up 5.4% year-over-year, but missed EPS estimates. Valuation ratios appear attractive with a P/E of 7.53 and P/S of 0.24, though negative shareholder equity and high debt levels remain concerns. Recent news includes a planned CFO transition in December 2026 and inclusion in TIME's America's Best Companies list.

The outlook is cautious due to inconsistent earnings performance and a highly leveraged balance sheet, but low valuation metrics and analyst consensus leaning buy (53.84%) suggest potential upside if operational improvements and debt reduction continue. Key risks include execution challenges, competitive pressures, and sensitivity to macroeconomic conditions.

NU stock trades at $13.47, down 2.81% over the past day, with technical indicators signaling a bearish trend. The company reported strong fundamentals, with revenue growing from $3.0B in 2022 to $10.63B in 2025 and net income turning positive to $2.87B. Recent earnings have shown mixed results, with two misses in the last three quarters, but Q2 2026 results are anticipated as a potential catalyst. Analyst consensus remains bullish with a $14.98 price target, though technical weakness persists near support at $13.

The outlook for NU is supported by robust revenue growth and profitability improvements, but near-term risks include competitive pressures and technical bearishness. Upside potential exists if Q2 earnings beat expectations, while failure to meet targets could exacerbate selling pressure. Investors should weigh strong fundamentals against current market sentiment and upcoming earnings.